Both the products are Gadolinium based Magnetic Resonance Imaging (MRI) contrast agents and will be the first set of contrast agent products in Zydus’ injectable portfolio for the US market
Agreement further expands Aptar Pharma’s leading respiratory portfolio
Vonoprazan is used in the treatment of disorders related to Gastroesophageal Reflux Disease (GERD)
The JV will establish a state-of-the-art manufacturing facility to manufacture fermented animal free protein to cater to the global markets
To co-develop and co-commercialize MK-6070, an investigational delta-like ligand 3 (DLL3) targeting T-cell engager, worldwide except for Japan where Merck retains exclusive rights
Pharmaceuticals and Consumer Health report higher sales (Fx & portfolio adj.) and lower earnings
GSK and Flagship to jointly fund up to $150 million upfront
Access to breast milk for sick newborns admitted in intensive care units plays a lifesaving role
Dr. Reddy's Laboratories has reported total income of Rs. 7,672.7 crores during the period ended June 30, 2024
Subscribe To Our Newsletter & Stay Updated
